MedElevator Войти в исследования
← Поиск публикаций

DOI 10.6061/clinics/2021/e3286

Медицинская библиотека · Clinics (Sao Paulo, Brazil) · 2021

Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients.

Finsterer Josef, Scorza Fulvio A, Scorza Carla A

СтатьяОбзорПеревод пока не подготовлен

Аннотация

SARS-CoV-2 vaccinations are not free from side effects. Usually, they are mild or moderate but occasionally severe. One of these severe side effects is Guillain-Barré syndrome (GBS). This review summarizes and discusses GBS as a side effect of SARS-CoV-2 vaccinations (SCoVaG) based on recent research reports. Altogether, nine articles reporting 18 patients with SCoVaG were identified and one more report on another patient is under review. The age for the studies ranged between 20-86y. Nine patients were male, and ten were female. In all 19 patients, SCoVaG developed after the first dose of the vaccine. The Astra Zeneca vaccine was used in fourteen patients, the Pfizer vaccine in four patients, and the Johnson & Johnson vaccine was applied in one patient. The latency between vaccination and onset of GBS ranged from 3h to 39d. The treatment of SCoVaG included IVIGs (n=13), steroids (n=3), or no therapy (n=3). Six patients required mechanical ventilation. Only a single patient recovered completely and partial recovery was achieved in nine patients. In conclusion, GBS may develop time-linked to the first dose of a SARS-CoV-2 vaccination. Though a causal relationship between SARS-CoV-2 vaccinations and SCoVaG remains speculative, more evidence is in favour than against it.

Для цитирования: Finsterer Josef, Scorza Fulvio A, Scorza Carla A. Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients.. Clinics (Sao Paulo, Brazil). 2021. DOI: 10.6061/clinics/2021/e3286.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.